Close Menu

NEW YORK – The US Centers for Medicare and Medicaid Services released a draft decision memo on Friday describing criteria for the coverage of current and future blood-based colorectal cancer screening tests.

The memo, which is currently open for public comment, has implications for a number of companies developing circulating tumor DNA and epigenomic tests in the space, and at least one firm currently marketing a blood-based assay, Epigenomics' Epi proColon.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.